We are live on ! Find out more
AEMD icon

Aethlon Medical

12 hedge funds and large institutions have $1.26M invested in Aethlon Medical in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1212 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

25% less capital invested

Capital invested by funds: $1.69M → $1.26M (-$427K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q3 2018 in Review

12 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2018, worth a combined $1.26M — down 25% from $1.69M a quarter earlier.

Fund positioning in AEMD was balanced in Q3 2018: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $14K. The largest seller was Millennium Management, exiting entirely with an estimated $256K sold.

  • 12 institutional investors held Aethlon Medical (AEMD) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $1.26M of Aethlon Medical stock for Q3 2018, down 25% quarter-over-quarter.
  • 2 funds opened new Aethlon Medical positions in Q3 2018 and 2 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q3 2018 was Citadel Advisors, an estimated $14K added.
  • The largest Aethlon Medical seller in Q3 2018 was Millennium Management, an estimated $256K sold.

Based on aggregated 13F filings for Q3 2018.